Covestor’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83K Sell
3,238
-141
-4% -$3.27K 0.05% 474
2026
Q1
$70K Sell
3,379
-1,530
-31% -$34.5K 0.05% 488
2025
Q4
$116K Sell
4,909
-915
-16% -$22.3K 0.06% 494
2025
Q3
$145K Buy
5,824
+1,657
+40% +$35.7K 0.08% 356
2025
Q2
$96K Buy
4,167
+3,744
+885% +$86.7K 0.06% 579
2025
Q1
$10K Sell
423
-2
-0.5% -$46 0.01% 1510
2024
Q4
$8K Sell
425
-39
-8% -$773 0.01% 1648
2024
Q3
$8K Sell
464
-4,261
-90% -$81.3K 0.01% 1668
2024
Q2
$82K Sell
4,725
-567
-11% -$10K 0.05% 609
2024
Q1
$104K Buy
5,292
+1,076
+26% +$22.7K 0.07% 521
2023
Q4
$97K Sell
4,216
-2,487
-37% -$55.7K 0.07% 513
2023
Q3
$154K Buy
6,703
+514
+8% +$13.1K 0.12% 202
2023
Q2
$162K Buy
6,189
+5,929
+2,280% +$157K 0.12% 194
2023
Q1
$7K Buy
260
+3
+1% +$79 0.01% 1481
2022
Q4
$6K Buy
257
+250
+3,571% +$6.96K ﹤0.01% 1532
2022
Q3
$0 Sell
7
-7
-50% -$259 ﹤0.01% 2450
2022
Q2
$0 Sell
14
-4
-22% -$102 ﹤0.01% 2260
2022
Q1
$0 Sell
18
-5
-22% -$118 ﹤0.01% 2368
2021
Q4
$1K Buy
+23
New +$573 ﹤0.01% 1892

Other funds holding PRVA

Covestor's PRVA Position: Q2 2026 in Review

Covestor reduced its Privia Health (PRVA) stake by 4.2% in Q2 2026, selling an estimated $3.27K and leaving 3,238 shares worth $83K. The position accounts for 0.05% of the portfolio, ranked #474.

Covestor first reported a position in PRVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $162K in Q2 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Covestor held 3,238 shares of Privia Health worth $83K as of Q2 2026.
  • Covestor sold 141 Privia Health shares in Q2 2026, an estimated $3.27K.
  • Privia Health made up 0.05% of Covestor's portfolio in Q2 2026, its #474 holding.
  • Covestor first reported a position in Privia Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Privia Health position peaked at $162K in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.